Cross-Sector entity
Judge Guido Calabresi is most often covered alongside 2nd U.S. Circuit Court of Appeals, which appears in 2 of these 2 stories. Coverage clusters in pharma, which accounts for 1 of those 2, with the remainder spread across 1 other category.
2 verified stories tracked
Last mentioned: Jul 25, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Judge Guido Calabresi is most often covered alongside 2nd U.S. Circuit Court of Appeals, which appears in 2 of these 2 stories. Coverage clusters in pharma, which accounts for 1 of those 2, with the remainder spread across 1 other category. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention Judge Guido Calabresi, all published on July 25, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Judge Guido Calabresi. Shared-story counts are live from our verified record — not editorial picks.
The legal reinstatement of Tylenol-autism lawsuits pressures healthcare providers to reconcile conflicting evidence on acetaminophen safety in pregnancy, potentially altering clinical guidance, patient counseling, and EHR decision support.
The 2nd Circuit ruling revives mass tort litigation linking prenatal acetaminophen to autism, exposing Kenvue and retailers to billions in potential liability. The decision hinges on admissibility of novel scientific evidence, challenging Daubert standards and regulatory orthodoxy.
Source: fox5atlanta.com · fox32chicago.com
